You are here: Industry Insights > Sanofi

News List

US Patent Office Rules Sanofi's Formulation Patents on Multibillion-Dollar Lantus Invalid americanpharmaceuticalreview
December 14, 2018
Mylan announced the U.S. Patent and Trademark Appeal Board (PTAB) has ruled in favor of Mylan in its inter partes review (IPR) proceedings and .....
Sanofi may airlift flu shots into the U.K. in no-deal Brexit fiercepharma
December 12, 2018
Several drugmakers are already stockpiling drugs in case of a no-deal Brexit.
Boehringer's France restructure will cull over 300 jobs pharmafile
December 12, 2018
Boehringer Ingelheim is set to follow in the recent steps of Sanofi with the announcement of a cull of over 300 employees in France – around 10% of the company’s total workforce in the country.
Sanofi's controversial Dengvaxia picks up FDA priority review fiercepharma
December 11, 2018
Sanofi has weathered controversy with its world-first dengue vaccine, Dengvaxia, but the company is pressing ahead...
Sanofi plots 670 layoffs in France as local tensions brew fiercepharma
December 10, 2018
Sanofi may be on the up-and-up thanks to its vaccines unit and new anti-inflammatory star Dupixent, but the company still intends to shed more than 600 jobs in its home country over the next couple of years.
Sanofi announce cull of 670 French jobs pharmafile
December 07, 2018
French pharma giant Sanofi has said that it will cut 670 jobs in France over the next two years. The company currently employs 25,000 employees across France.
Sanofi inks research deal to create digital asthma lab fiercepharma
December 06, 2018
Sanofi plans to take asthma research where it has not gone before.
Sanofi, Sema4, Mount Sinai Collaborate on Largest Asthma Study of Its Kind firstwordpharma
December 05, 2018
Sema4, a patient-centered predictive health company, and the Mount Sinai Health System today announced the launch of a five-year collaborative study with Sanofi designed to provide new insights into the biological mechanisms and other factors implicated i
Sanofi's controversial Dengvaxia picks up FDA priority review fiercepharma
December 04, 2018
Sanofi has weathered controversy with its world-first dengue vaccine, Dengvaxia, but the company is pressing ahead, and on Tuesday said the FDA had not only accepted its application for approval, but also granted a priority review.
Why China's flu vaccine supply is suffering this season fiercepharma
December 04, 2018
It isn’t a scene one would expect after the world battled a severe flu season. But in China, supply of flu vaccines this season has come down, thanks to reduced offering from Sanofi Pasteur..

Previous page 1 2 3 4 5 6 7 8 9 10 ... 43 44 Next page